BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21633102)

  • 21. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
    Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
    Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
    Bartel C; Obermüller N; Rummel MJ; Geiger H; Hauser IA
    Clin Nephrol; 2008 Apr; 69(4):285-9. PubMed ID: 18397703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.
    Naghashpour M; Setoodeh R; Moscinski L; Bergier G; McCardle T; Glass F; Sokol L
    Am J Dermatopathol; 2011 Dec; 33(8):855-7. PubMed ID: 22042261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
    Foon KA; Boyiadzis M; Land SR; Marks S; Raptis A; Pietragallo L; Meisner D; Laman A; Sulecki M; Butchko A; Schaefer P; Lenzer D; Tarhini A
    J Clin Oncol; 2009 Feb; 27(4):498-503. PubMed ID: 19075274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphocytic leukemia].
    Zagoskina TP; Tkachenko SB; Golubeva ME; Kudriavtseva AV; Isaeva NV; Malykh OV
    Ter Arkh; 2010; 82(1):35-9. PubMed ID: 20364698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.
    Hill PA; Firkin F; Dwyer KM; Lee P; Murphy BF
    Pathology; 2002 Apr; 34(2):138-43. PubMed ID: 12009095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract]   [Full Text] [Related]  

  • 28. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
    O'Brien S; Moore JO; Boyd TE; Larratt LM; Skotnicki A; Koziner B; Chanan-Khan AA; Seymour JF; Bociek RG; Pavletic S; Rai KR
    J Clin Oncol; 2007 Mar; 25(9):1114-20. PubMed ID: 17296974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
    Bosch F; Abrisqueta P; Villamor N; Terol MJ; González-Barca E; Ferra C; González Diaz M; Abella E; Delgado J; Carbonell F; García Marco JA; Escoda L; Ferrer S; Monzó E; González Y; Estany C; Jarque I; Salamero O; Muntañola A; Montserrat E
    J Clin Oncol; 2009 Sep; 27(27):4578-84. PubMed ID: 19704063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent Proliferative Glomerulonephritis With Monoclonal IgG Deposits After a Renal Transplant Which Was Insensitive to Pulse Therapy Remitted by Double Filtration Plasmapheresis.
    Wu D; Chen JS; Cheng DR; Chen H; Li X; Ji SM; Xie KN; Ni XF; Liu ZH; Wen JQ
    Exp Clin Transplant; 2015 Oct; 13(5):467-70. PubMed ID: 25275829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
    Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
    Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1κ subtype in a kidney allograft.
    Tsuji T; Miura M; Yanai M; Itami H; Ishii Y; Akimoto M; Fukasawa Y
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():44-7. PubMed ID: 26976360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent proliferative glomerulonephritis with monoclonal IgG deposits of IgG2λ subtype in a transplanted kidney: a case report.
    Sumida K; Ubara Y; Marui Y; Nakamura M; Takaichi K; Tomikawa S; Fujii T; Ohashi K
    Am J Kidney Dis; 2013 Sep; 62(3):587-90. PubMed ID: 23474011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membranoproliferative glomerulonephritis secondary to chronic myeloid leukemia.
    Subramanian M; Kilara N; Manjunath R; Mysorekar V
    Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):738-41. PubMed ID: 20587884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative glomerulonephritis with monoclonal immunoglobulin A light-chain deposits in the renal allograft.
    Setoguchi K; Kawashima Y; Tokumoto T; Toma H; Mizoguchi S; Horita S; Yamaguchi Y; Tanabe K
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():49-51. PubMed ID: 24842824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM; Kantarjian HM; Cortes J; Thomas DA; Faderl S; Garcia-Manero G; Verstovsek S; Ferrajoli A; Wierda W; Alvarado Y; O'Brien SM; Albitar M; Keating MJ; Giles FJ
    Cancer; 2003 Apr; 97(7):1711-20. PubMed ID: 12655528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
    Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotic syndrome associated with chronic lymphocytic leukemia resistant to immunosuppressive drugs: remission obtained by splenectomy.
    Halimi JM; Lavabre-Bertrand T; Beraud JJ; Canaud B
    Clin Nephrol; 1996 Apr; 45(4):273-6. PubMed ID: 8861805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.